$612 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 59 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 95.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMMU | Sell | IMMUNOMEDICS INC | $85,469,000 | -21.6% | 5,850,000 | -13.3% | 13.96% | -32.2% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $71,994,000 | +131.2% | 4,260,000 | +9.5% | 11.76% | +100.1% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $54,791,000 | +11.4% | 1,115,000 | +2.6% | 8.95% | -3.6% |
| XBI | Buy | SPDR SERIES TRUSTput | $43,866,000 | +47.7% | 500,000 | +42.9% | 7.16% | +27.7% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $35,578,000 | +67.3% | 544,000 | +2.4% | 5.81% | +44.7% |
| ARGX | Buy | ARGENX SEsponsored adr | $32,483,000 | +59.3% | 403,821 | +25.0% | 5.30% | +37.8% |
| IWM | Sell | ISHARES TRput | $30,367,000 | -20.3% | 200,000 | -20.0% | 4.96% | -31.1% |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $29,792,000 | +385.4% | 1,154,722 | +156.6% | 4.87% | +319.8% |
| KDMN | Buy | KADMON HLDGS INC | $25,288,000 | +42.1% | 5,950,000 | +21.1% | 4.13% | +23.0% |
| VCYT | Buy | VERACYTE INC | $18,448,000 | -14.3% | 3,318,000 | +0.7% | 3.01% | -25.8% |
| INTEC PHARMA LTD JERUSALEM | $17,231,000 | +22.8% | 2,724,283 | 0.0% | 2.81% | +6.2% | ||
| CEMI | Buy | CHEMBIO DIAGNOSTICS INC | $16,053,000 | +13.7% | 2,006,667 | +16.6% | 2.62% | -1.6% |
| QQQ | New | POWERSHARES QQQ TRUSTput | $13,612,000 | – | 85,000 | +100.0% | 2.22% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $12,706,000 | – | 1,762,206 | +100.0% | 2.08% | – |
| VRAY | Sell | VIEWRAY INC | $11,914,000 | -32.8% | 1,852,878 | -3.3% | 1.95% | -41.9% |
| IRIX | IRIDEX CORP | $11,440,000 | -24.9% | 2,000,000 | 0.0% | 1.87% | -35.1% | |
| ASMB | New | ASSEMBLY BIOSCIENCES INCcall | $7,617,000 | – | 155,000 | +100.0% | 1.24% | – |
| AVXS | Buy | AVEXIS INC | $7,415,000 | +26.7% | 60,000 | +13.4% | 1.21% | +9.6% |
| TNDM | New | TANDEM DIABETES CARE INC | $6,678,000 | – | 1,346,360 | +100.0% | 1.09% | – |
| CASM | Buy | CAS MED SYS INC | $6,573,000 | +65.4% | 5,216,998 | +1.1% | 1.07% | +43.2% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $6,563,000 | – | 350,000 | +100.0% | 1.07% | – |
| LLY | New | LILLY ELI & COput | $5,803,000 | – | 75,000 | +100.0% | 0.95% | – |
| EEM | New | ISHARES TRput | $4,828,000 | – | 100,000 | +100.0% | 0.79% | – |
| FXI | Sell | ISHARES TRput | $3,543,000 | -23.3% | 75,000 | -25.0% | 0.58% | -33.6% |
| CUTR | New | CUTERA INC | $3,518,000 | – | 70,000 | +100.0% | 0.58% | – |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INCcall | $3,436,000 | +3804.5% | 203,300 | +1748.2% | 0.56% | +3200.0% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $3,070,000 | +8.5% | 100,000 | -35.5% | 0.50% | -6.2% |
| FENC | FENNEC PHARMACEUTICALS INC | $3,024,000 | +20.7% | 250,000 | 0.0% | 0.49% | +4.4% | |
| ARMO | New | ARMO BIOSCIENCES INC | $2,993,000 | – | 80,000 | +100.0% | 0.49% | – |
| New | INOTEK PHARMACEUTICALS CORPnote 5.750% 8/0 | $2,871,000 | – | 3,000,000 | +100.0% | 0.47% | – | |
| Sell | NABRIVA THERAPEUTICS PLC | $2,815,000 | -18.8% | 559,739 | -3.5% | 0.46% | -29.8% | |
| UTHR | New | UNITED THERAPEUTICS CORP DELput | $2,809,000 | – | 25,000 | +100.0% | 0.46% | – |
| VIVE | Buy | VIVEVE MED INC | $2,508,000 | +16.4% | 685,215 | +58.1% | 0.41% | +0.7% |
| EDIT | Buy | EDITAS MEDICINE INCput | $1,824,000 | +48.4% | 55,000 | +37.5% | 0.30% | +28.4% |
| AERI | New | AERIE PHARMACEUTICALS INCcall | $1,628,000 | – | 30,000 | +100.0% | 0.27% | – |
| RMTI | Sell | ROCKWELL MED INCput | $1,589,000 | -38.0% | 305,000 | -30.7% | 0.26% | -46.3% |
| NTLA | New | INTELLIA THERAPEUTICS INCput | $1,582,000 | – | 75,000 | +100.0% | 0.26% | – |
| FIXX | New | HOMOLOGY MEDICINES INC | $1,477,000 | – | 79,000 | +100.0% | 0.24% | – |
| TWTR | New | TWITTER INCcall | $1,451,000 | – | 50,000 | +100.0% | 0.24% | – |
| RARX | New | RA PHARMACEUTICALS INC | $1,434,000 | – | 270,000 | +100.0% | 0.23% | – |
| TSRO | New | TESARO INCcall | $1,429,000 | – | 25,000 | +100.0% | 0.23% | – |
| BEAT | New | BIOTELEMETRY INC | $1,242,000 | – | 40,000 | +100.0% | 0.20% | – |
| AXDX | New | ACCELERATE DIAGNOSTICS INCcall | $1,143,000 | – | 50,000 | +100.0% | 0.19% | – |
| AMPE | New | AMPIO PHARMACEUTICALS INCput | $1,105,000 | – | 325,000 | +100.0% | 0.18% | – |
| AMAG | Sell | AMAG PHARMACEUTICALS INCput | $1,008,000 | -42.6% | 50,000 | -62.3% | 0.16% | -50.3% |
| ALIM | ALIMERA SCIENCES INC | $1,004,000 | -22.5% | 974,318 | 0.0% | 0.16% | -33.1% | |
| SGMO | New | SANGAMO THERAPEUTICS INCput | $950,000 | – | 50,000 | +100.0% | 0.16% | – |
| NVTRQ | New | NUVECTRA CORP | $869,000 | – | 66,724 | +100.0% | 0.14% | – |
| OSUR | Sell | ORASURE TECHNOLOGIES INCput | $845,000 | -55.2% | 50,000 | -50.0% | 0.14% | -61.2% |
| ANIP | New | ANI PHARMACEUTICALS INCput | $833,000 | – | 14,300 | +100.0% | 0.14% | – |
| TWTR | New | TWITTER INCput | $725,000 | – | 25,000 | +100.0% | 0.12% | – |
| GKOS | Sell | GLAUKOS CORPput | $617,000 | -22.4% | 20,000 | -35.5% | 0.10% | -32.7% |
| AERI | New | AERIE PHARMACEUTICALS INCput | $543,000 | – | 10,000 | +100.0% | 0.09% | – |
| CRSP | New | CRISPR THERAPEUTICS AGput | $457,000 | – | 10,000 | +100.0% | 0.08% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDput | $427,000 | – | 25,000 | +100.0% | 0.07% | – |
| ENDP | New | ENDO INTL PLCput | $356,000 | – | 60,000 | +100.0% | 0.06% | – |
| TRXC | Buy | TRANSENTERIX INCput | $307,000 | +51.2% | 180,000 | +71.4% | 0.05% | +31.6% |
| MNKD | Sell | MANNKIND CORPput | $302,000 | -24.5% | 132,500 | -23.2% | 0.05% | -35.5% |
| ONS | ONCOBIOLOGICS INC | $26,000 | -31.6% | 29,082 | 0.0% | 0.00% | -42.9% | |
| AVEO | Exit | AVEO PHARMACEUTICALS INCcall | $0 | – | -12,000 | -100.0% | -0.01% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INCput | $0 | – | -2,500 | -100.0% | -0.01% | – |
| TGTX | Exit | TG THERAPEUTICS INCcall | $0 | – | -10,000 | -100.0% | -0.02% | – |
| NEOS | Exit | NEOS THERAPEUTICS INCput | $0 | – | -25,000 | -100.0% | -0.05% | – |
| LXRX | Exit | LEXICON PHARMACEUTICALS INCput | $0 | – | -32,500 | -100.0% | -0.06% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -124,338 | -100.0% | -0.07% | – |
| EVH | Exit | EVOLENT HEALTH INCcall | $0 | – | -32,500 | -100.0% | -0.08% | – |
| ONCE | Exit | SPARK THERAPEUTICS INCput | $0 | – | -10,000 | -100.0% | -0.10% | – |
| MDXG | Exit | MIMEDX GROUP INCput | $0 | – | -50,000 | -100.0% | -0.12% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -43,900 | -100.0% | -0.12% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INCcall | $0 | – | -46,300 | -100.0% | -0.12% | – |
| EVTC | Exit | EVERTEC INCput | $0 | – | -55,000 | -100.0% | -0.14% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INCput | $0 | – | -55,000 | -100.0% | -0.19% | – |
| IMDZ | Exit | IMMUNE DESIGN CORP | $0 | – | -274,100 | -100.0% | -0.20% | – |
| MDCO | Exit | MEDICINES COcall | $0 | – | -40,000 | -100.0% | -0.21% | – |
| VRAY | Exit | VIEWRAY INCcall | $0 | – | -120,000 | -100.0% | -0.21% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INCput | $0 | – | -52,500 | -100.0% | -0.22% | – |
| NEOS | Exit | NEOS THERAPEUTICS INCcall | $0 | – | -115,500 | -100.0% | -0.22% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -152,300 | -100.0% | -0.26% | – |
| TDOC | Exit | TELADOC INCput | $0 | – | -40,000 | -100.0% | -0.26% | – |
| EXEL | Exit | EXELIXIS INCcall | $0 | – | -50,000 | -100.0% | -0.29% | – |
| SGEN | Exit | SEATTLE GENETICS INCput | $0 | – | -30,000 | -100.0% | -0.30% | – |
| STML | Exit | STEMLINE THERAPEUTICS INCcall | $0 | – | -105,000 | -100.0% | -0.31% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INCcall | $0 | – | -86,000 | -100.0% | -0.31% | – |
| JUNO | Exit | JUNO THERAPEUTICS INCcall | $0 | – | -37,000 | -100.0% | -0.32% | – |
| NKTR | Exit | NEKTAR THERAPEUTICSput | $0 | – | -30,000 | -100.0% | -0.34% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGcall | $0 | – | -80,000 | -100.0% | -0.36% | – |
| EDIT | Exit | EDITAS MEDICINE INCcall | $0 | – | -64,000 | -100.0% | -0.37% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTLcall | $0 | – | -100,000 | -100.0% | -0.39% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL INcall | $0 | – | -46,000 | -100.0% | -0.40% | – |
| NKTR | Exit | NEKTAR THERAPEUTICScall | $0 | – | -36,000 | -100.0% | -0.41% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -92,500 | -100.0% | -0.43% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INCput | $0 | – | -40,000 | -100.0% | -0.43% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -80,000 | -100.0% | -0.46% | – |
| LOXO | Exit | LOXO ONCOLOGY INCput | $0 | – | -30,000 | -100.0% | -0.48% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -90,000 | -100.0% | -0.51% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS INcall | $0 | – | -80,000 | -100.0% | -0.59% | – |
| SGEN | Exit | SEATTLE GENETICS INCcall | $0 | – | -80,000 | -100.0% | -0.81% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -311,169 | -100.0% | -0.82% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -900,000 | -100.0% | -0.83% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -420,000 | -100.0% | -0.98% | – |
| EDGE | Exit | EDGE THERAPEUTICS INC | $0 | – | -943,906 | -100.0% | -1.67% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -300,000 | -100.0% | -2.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| KURA ONCOLOGY INC. COMMON STOCK | 20 | Q2 2024 | 8.1% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| APELLIS PHARMACEUTICALS INC | 18 | Q4 2023 | 18.4% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.